OnKure Therapeutics, Inc.
OKUR
$4.25
-$0.15-3.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 192.11M | 59.05M | 70.33M | 83.37M | 96.66M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.38M | 1.79M | 1.20M | 1.18M | 1.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 197.48M | 60.84M | 71.53M | 84.55M | 98.17M |
|
|
|||||
| Total Current Assets | 197.48M | 60.84M | 71.53M | 84.55M | 98.17M |
| Net Property, Plant & Equipment | 807.00K | 1.01M | 1.21M | 1.40M | 1.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 405.00K | 273.00K | 104.00K | 116.00K | 109.00K |
| Total Assets | 198.69M | 62.12M | 72.84M | 86.07M | 99.88M |
|
|
|||||
| Total Accounts Payable | 11.02M | 1.43M | 1.29M | 2.38M | 2.34M |
| Total Accrued Expenses | 2.90M | 3.94M | 4.39M | 4.66M | 5.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 409.00K | 549.00K | 567.00K | 556.00K | 546.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.33M | 5.92M | 6.25M | 7.60M | 8.79M |
|
|
|||||
| Total Current Liabilities | 14.33M | 5.92M | 6.25M | 7.60M | 8.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 120.00K | 267.00K | 409.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.00K | 12.00K | 40.00K | 40.00K | 40.00K |
| Total Liabilities | 14.34M | 5.93M | 6.41M | 7.90M | 9.23M |
|
|
|||||
| Common Stock & APIC | 413.75M | 270.43M | 267.17M | 264.21M | 261.30M |
| Retained Earnings | -229.40M | -214.24M | -200.74M | -186.04M | -170.65M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 184.35M | 56.18M | 66.43M | 78.17M | 90.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 184.35M | 56.18M | 66.43M | 78.17M | 90.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 184.35M | 56.18M | 66.43M | 78.17M | 90.65M |
|
|
|||||